Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of
Unbelievable Jeff! IriusRisk introduces an AI-powered tool which can generate threat models from images
The threat modeling platform launches ‘Jeff: AI Assistant’, a world first in terms of creating threat models through language and images. The new feature is the latest development in IriusRisk’s
Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions
Quantexa earned a top ranking in the RiskTech100® 2025 Report, highlighting its strength and innovation in the expanding risk technology and compliance market LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) —
WGO INVESTOR NEWS: Winnebago Industries, Inc. Investors that Suffered Losses Are Encouraged to Contact RLF About Ongoing Investigation into the Company (NYSE: WGO)
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Winnebago
FLUX INVESTOR NEWS: Flux Power Holdings, Inc. Investors that Suffered Losses are Encouraged to Contact RLF About Ongoing Investigation into the Company (NASDAQ: FLUX)
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Flux
LNW INVESTOR NEWS: Light & Wonder, Inc. Investors that Suffered Losses are Encouraged to Contact RLF About Ongoing Investigation into the Company (Nasdaq: LNW)
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of